Pharmacokinetic Study of Belviq in Adult Korean Volunteers
Status:
Completed
Trial end date:
2013-10-01
Target enrollment:
Participant gender:
Summary
A randomized, double-blind, placebo-controlled, single-dose, dose escalation study (Phase I)
to evaluate the tolerability and pharmacokinetics of Belviq in adult Korean volunteers.